Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Open-label to the Route of Administration, Single-blind to the ID Doses, Randomised, Active-controlled, Parallel Study to Evaluate the Safe Usability of 4Fluart ID Suspension for Injection in Adult Subjects

NCT03448705 is registered in ClinicalTrials.gov with Fluart Innovative Vaccine Ltd, Hungary as lead sponsor.

NCT NCT03448705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03448705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Open-label to the Route of Administration, Single-blind to the ID Doses, Randomised, Active-controlled, Parallel Study to Evaluate the Safe Usability of 4Fluart ID Suspension for Injection in Adult Subjects
Lead sponsor
Fluart Innovative Vaccine Ltd, Hungary
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2018
Completion date
April 3, 2018
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human influenza